IE38515L - Cyclopentane (prostanoic acid) derivatives - Google Patents

Cyclopentane (prostanoic acid) derivatives

Info

Publication number
IE38515L
IE38515L IE732066A IE206673A IE38515L IE 38515 L IE38515 L IE 38515L IE 732066 A IE732066 A IE 732066A IE 206673 A IE206673 A IE 206673A IE 38515 L IE38515 L IE 38515L
Authority
IE
Ireland
Prior art keywords
trimethylsilyloxy
trans
cis
epi
trimethylsilyl
Prior art date
Application number
IE732066A
Other versions
IE38515B1 (en
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of IE38515L publication Critical patent/IE38515L/en
Publication of IE38515B1 publication Critical patent/IE38515B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/516Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of nitrogen-containing compounds to >C = O groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

1402035 Silylated prostadienoates IMPERIAL CHEMICAL INDUSTRIES Ltd 13 Nov 1973 [7 Dec 1972] 56501/72 Heading C3S [Also in Divisions C2 and A5] Trimethylsilyl 16 - (3 - chlorophenoxy)- 9,11α,15 - tri(trimethylsilyloxy) - 17,18,19,20- tetranor - 5 - cis,13 - trans - 12 - epi - prostadienoate, trimethylsilyl 16 - (3 - chlorophenoxy) - 9 - methoxyimino - 11α,15 - di(trimethylsilyloxy) - 17,18,19,20 - tetranor - 5 - cis,13- trans - 12 - epi - prostadienoate, trimethylsilyl 16 - (3 - chlorophenoxy) - 2 - methyl - 9 - methoxyimino - - 11α,15 - di(trimethylsilyloxy)- 17,18,19,20 - tetranot - 5 - cis,13 trans - 12- epi - prostadienoate, trimethylsilyl 9,11α,15- tri(trimethylsilyloxy) - 5 - cis,13 - trans - 12- epi - prostadienoate, 9 - methoxyimino - 11α, 15- di(trimethylsilyloxy) - 5 - cis,13 - trans - 12 - epiprostadienoate, trimethylsilyl 2 - methyl - 9α,- 11α,15 - tri(trimethylsilyloxy) - 5 - cis,13- trans - 12 - epi - prostadienoate, trimethylsilyl 9 - methoxyimino - 2 - methyl - 11α,15 - di- (trimethylsilyloxy) - 5 - cis,13 - trans - 12 - epiprostadienoate, trimethylsilyl 20 - ethyl- 9α,11α,15 - tri(trimethylsilyloxy) - 5 - cis,13- trans - 12 - epi - prostadienoate, trimethysilyl 9 - methoxyimino - 11α,15 - di(trimethylsilyloxy) - 13 - trans - 12 - epi - prostenoate, trimethylsilyl 9α,11α,15 - tri(trimethylsilyloxy)- 13 - trans - 12 - epi - prostenoate, trimethylsilyl 16 - phenyl - 9α,11α,15 - tri(trimethylsilyloxy)- 17,18,19,20 - tetranor - 5 - cis,13 - trans - 12- epi - prostadienoate, 9 - methoxyimino - 16- phenyl - 11α,15 - di(trimethylsilyloxy) - 17,18,- 19, 20 - tetranor - 5 - cis,13 - trans - 12 - epiprostadienoate, trimethylsilyl 16 - (2 - naphthyloxy) - 9α,11α,15 - tri(trimethylsilyloxy)- 17,18,19,20 - tetranor - 5 - cis,13 - trans - 12- epi - prostadienoate and trimethylsilyl 16- (2 - naphthyloxy) - 11α,15 - di(trimethylsilyloxy) - 17,18,19,20 - tetranor - 5 - cis,13 - trans- 12 - epi - prostadienoate are prepared by standard methods. [GB1402035A]
IE2066/73A 1972-12-07 1973-11-15 Cyclopentane derivatives IE38515B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5650172A GB1402035A (en) 1972-12-07 1972-12-07 Cyclopentane derivatives

Publications (2)

Publication Number Publication Date
IE38515L true IE38515L (en) 1974-06-07
IE38515B1 IE38515B1 (en) 1978-03-29

Family

ID=10476784

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2066/73A IE38515B1 (en) 1972-12-07 1973-11-15 Cyclopentane derivatives

Country Status (13)

Country Link
JP (1) JPS5024252A (en)
AU (1) AU473283B2 (en)
BE (1) BE808398A (en)
CA (1) CA1016940A (en)
CH (1) CH605725A5 (en)
DE (1) DE2360893A1 (en)
ES (1) ES421274A1 (en)
FR (1) FR2209569B1 (en)
GB (1) GB1402035A (en)
IE (1) IE38515B1 (en)
LU (1) LU68940A1 (en)
NL (1) NL7316508A (en)
ZA (1) ZA738797B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0144459A1 (en) * 1983-12-09 1985-06-19 Dr. Willmar Schwabe GmbH & Co. Prostaglandins, their preparation and pharmaceutical compositions
JPS6240987A (en) * 1985-08-20 1987-02-21 Nippon Steel Corp Energy beam welding method
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2010102078A1 (en) 2009-03-04 2010-09-10 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure

Also Published As

Publication number Publication date
CH605725A5 (en) 1978-10-13
BE808398A (en) 1974-06-07
AU473283B2 (en) 1976-06-17
LU68940A1 (en) 1974-02-12
FR2209569B1 (en) 1978-07-28
GB1402035A (en) 1975-08-06
ZA738797B (en) 1974-07-31
JPS5024252A (en) 1975-03-15
IE38515B1 (en) 1978-03-29
AU6279773A (en) 1975-11-27
ES421274A1 (en) 1976-04-16
DE2360893A1 (en) 1974-06-12
CA1016940A (en) 1977-09-06
FR2209569A1 (en) 1974-07-05
NL7316508A (en) 1974-06-11

Similar Documents

Publication Publication Date Title
GB1409841A (en) Prostaglandins and the manufacture thereof
IE40157B1 (en) Prostanoic acid derivatives
CA1012435A (en) Mechanism for allowing blood bags to communicate with each other
IE40043L (en) 16, 17, 18, 19, 20-pentanorprostaglandins
IE38515L (en) Cyclopentane (prostanoic acid) derivatives
CA1030403A (en) Stabilizing linkage for an articulated vehicle
AU501389B2 (en) Prostaglandin analogues
IE37909L (en) Prostaglandin analogues
AU475680B2 (en) Improved suspension for vehicles
CA1018192A (en) Mining concentrator
CA1029374A (en) 2-substituted-5,6-dimethoxyindazoles
IE40235B1 (en) Cyclopentane derivatives
AU501954B2 (en) Velocity correction for videodiscs
GB1403501A (en) Prostaglandins and the preparation thereof
CA1003011A (en) Multidirectional resilient suspension for vehicles
GB1487037A (en) Prostaglandins
IE41600L (en) 3, 4 - dihydro - 2h - isoquinolin - 1 - thiones
AU499154B2 (en) 11, deoxy pge derivatives
CA1010373A (en) 90.degree. steering system
CA1023290A (en) Nucleoside cyclic phosphates by rna hydrolysis
AU8593575A (en) Wheel alignment
GB1535780A (en) 16-aryloxy-17,18,19,20-tetranoprostanoic acid and derivatives
GB1413831A (en) Prostatrienoic acid derivatives and process
AU519637B2 (en) 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
CA1024193A (en) Traction system